Delving into the Latest Updates on Hainan Demei Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Skin and Musculoskeletal Diseases

Other Diseases

Immune System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	3
Infectious Diseases	2
Nervous System Diseases	1
Hemic and Lymphatic Diseases	1
Neoplasms	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	3

Top 5 Target	Count

JAK1(Tyrosine-protein kinase JAK1)	1
TYK2(Tyrosine-protein kinase 2)	1
JAK1 x JAK2	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Phase 3

Other

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Ruxolitinib Phosphate ( JAK1 x JAK2 )	Dermatitis, Atopic More	Phase 3
CMS-D001 ( TYK2 )	Dermatitis, Atopic More	IND Approval
Povorcitinib ( JAK1 )	Hidradenitis Suppurativa More	IND Approval